Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT

14.98  +0.14 (+0.94%)

After market: 14.98 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XHR. XHR was compared to 129 industry peers in the Diversified REITs industry. XHR may be in some trouble as it scores bad on both profitability and health. XHR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year XHR was profitable.
In the past year XHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: XHR reported negative net income in multiple years.
XHR had a positive operating cash flow in 4 of the past 5 years.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

XHR has a Return On Assets of 0.83%. This is comparable to the rest of the industry: XHR outperforms 54.76% of its industry peers.
XHR's Return On Equity of 1.90% is in line compared to the rest of the industry. XHR outperforms 53.17% of its industry peers.
XHR has a Return On Invested Capital (2.47%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.83%
ROE 1.9%
ROIC 2.47%
ROA(3y)-0.73%
ROA(5y)-1.16%
ROE(3y)-1.57%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

The Profit Margin of XHR (2.33%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of XHR has declined.
The Operating Margin of XHR (8.35%) is worse than 84.92% of its industry peers.
In the last couple of years the Operating Margin of XHR has declined.
The Gross Margin of XHR (54.35%) is worse than 76.98% of its industry peers.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 8.35%
PM (TTM) 2.33%
GM 54.35%
OM growth 3YN/A
OM growth 5Y-4.65%
PM growth 3YN/A
PM growth 5Y-36.78%
GM growth 3Y13.94%
GM growth 5Y-1.03%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
XHR has less shares outstanding than it did 1 year ago.
XHR has less shares outstanding than it did 5 years ago.
XHR has a worse debt/assets ratio than last year.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that XHR is in the distress zone and has some risk of bankruptcy.
XHR has a Altman-Z score of 0.70. This is comparable to the rest of the industry: XHR outperforms 53.17% of its industry peers.
XHR has a debt to FCF ratio of 54.20. This is a negative value and a sign of low solvency as XHR would need 54.20 years to pay back of all of its debts.
XHR's Debt to FCF ratio of 54.20 is in line compared to the rest of the industry. XHR outperforms 54.76% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that XHR has dependencies on debt financing.
XHR has a Debt to Equity ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 54.2
Altman-Z 0.7
ROIC/WACC0.35
WACC7.05%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

XHR has a Current Ratio of 1.31. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, XHR is in line with its industry, outperforming 54.76% of the companies in the same industry.
A Quick Ratio of 1.31 indicates that XHR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.31, XHR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for XHR have decreased strongly by -43.90% in the last year.
The earnings per share for XHR have been decreasing by -33.93% on average. This is quite bad
Looking at the last year, XHR shows a decrease in Revenue. The Revenue has decreased by -0.45% in the last year.
Measured over the past years, XHR shows a decrease in Revenue. The Revenue has been decreasing by -0.63% on average per year.
EPS 1Y (TTM)-43.9%
EPS 3YN/A
EPS 5Y-33.93%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y40.49%
Revenue growth 5Y-0.63%
Sales Q2Q%2.06%

3.2 Future

The Earnings Per Share is expected to grow by 7.65% on average over the next years.
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.79% yearly.
EPS Next Y3.97%
EPS Next 2Y31.26%
EPS Next 3Y7.65%
EPS Next 5YN/A
Revenue Next Year1.45%
Revenue Next 2Y3.14%
Revenue Next 3Y2.79%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2 -3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 65.13, XHR can be considered very expensive at the moment.
XHR's Price/Earnings is on the same level as the industry average.
XHR is valuated expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
XHR is valuated quite expensively with a Price/Forward Earnings ratio of 51.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 60.32% of the companies listed in the same industry.
XHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 65.13
Fwd PE 51.14
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 63.49% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as XHR.
Industry RankSector Rank
P/FCF 59.24
EV/EBITDA 12.87
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)16.4
PEG (5Y)N/A
EPS Next 2Y31.26%
EPS Next 3Y7.65%

2

5. Dividend

5.1 Amount

XHR has a Yearly Dividend Yield of 3.23%. Purely for dividend investing, there may be better candidates out there.
XHR's Dividend Yield is slightly below the industry average, which is at 18.51.
XHR's Dividend Yield is a higher than the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 3.23%

5.2 History

The dividend of XHR decreases each year by -17.85%.
XHR has been paying a dividend for over 5 years, so it has already some track record.
The dividend of XHR decreased recently.
Dividend Growth(5Y)-17.85%
Div Incr Years1
Div Non Decr Years1
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

192.33% of the earnings are spent on dividend by XHR. This is not a sustainable payout ratio.
DP192.33%
EPS Next 2Y31.26%
EPS Next 3Y7.65%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (1/21/2025, 8:04:00 PM)

After market: 14.98 0 (0%)

14.98

+0.14 (+0.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners92.47%
Inst Owner Change-0.34%
Ins Owners0.87%
Ins Owner Change0%
Market Cap1.53B
Analysts75.38
Price Target16.54 (10.41%)
Short Float %3.77%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 3.23%
Yearly Dividend0.42
Dividend Growth(5Y)-17.85%
DP192.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.27%
Min EPS beat(2)9.11%
Max EPS beat(2)41.44%
EPS beat(4)4
Avg EPS beat(4)144.16%
Min EPS beat(4)9.11%
Max EPS beat(4)362.05%
EPS beat(8)5
Avg EPS beat(8)164.69%
EPS beat(12)7
Avg EPS beat(12)114.37%
EPS beat(16)10
Avg EPS beat(16)92.86%
Revenue beat(2)0
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.92%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)2.48%
Revenue beat(8)3
Avg Revenue beat(8)0.03%
Revenue beat(12)6
Avg Revenue beat(12)1.83%
Revenue beat(16)10
Avg Revenue beat(16)2.55%
PT rev (1m)0.89%
PT rev (3m)2.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-88.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 65.13
Fwd PE 51.14
P/S 1.48
P/FCF 59.24
P/OCF 7.89
P/B 1.21
P/tB 1.21
EV/EBITDA 12.87
EPS(TTM)0.23
EY1.54%
EPS(NY)0.29
Fwd EY1.96%
FCF(TTM)0.25
FCFY1.69%
OCF(TTM)1.9
OCFY12.67%
SpS10.12
BVpS12.4
TBVpS12.35
PEG (NY)16.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 1.9%
ROCE 3.12%
ROIC 2.47%
ROICexc 2.62%
ROICexgc 2.66%
OM 8.35%
PM (TTM) 2.33%
GM 54.35%
FCFM 2.5%
ROA(3y)-0.73%
ROA(5y)-1.16%
ROE(3y)-1.57%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-3.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-2.78%
OM growth 3YN/A
OM growth 5Y-4.65%
PM growth 3YN/A
PM growth 5Y-36.78%
GM growth 3Y13.94%
GM growth 5Y-1.03%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 54.2
Debt/EBITDA 6.54
Cap/Depr 131.68%
Cap/Sales 16.26%
Interest Coverage 1.08
Cash Conversion 90.63%
Profit Quality 107.15%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 0.7
F-Score5
WACC7.05%
ROIC/WACC0.35
Cap/Depr(3y)138.99%
Cap/Depr(5y)129.28%
Cap/Sales(3y)18.98%
Cap/Sales(5y)20.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.9%
EPS 3YN/A
EPS 5Y-33.93%
EPS Q2Q%12.5%
EPS Next Y3.97%
EPS Next 2Y31.26%
EPS Next 3Y7.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y40.49%
Revenue growth 5Y-0.63%
Sales Q2Q%2.06%
Revenue Next Year1.45%
Revenue Next 2Y3.14%
Revenue Next 3Y2.79%
Revenue Next 5YN/A
EBIT growth 1Y-16.8%
EBIT growth 3YN/A
EBIT growth 5Y-5.24%
EBIT Next Year145.4%
EBIT Next 3Y40.13%
EBIT Next 5YN/A
FCF growth 1Y112.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.18%
OCF growth 3YN/A
OCF growth 5Y-4.87%